Foam • 5%/0.1%/0.1%/0.025%/2%/ml • 1 count
$250.00
Form
Foam
Strength
5%/0.1%/0.1%/0.025%/2%/ml
Quantity
1100
Minoxidil / Melatonin / Finasteride / Tretinoin / Caffeine is a compounded topical formulation designed for multi-mechanism support of hair growth and scalp health, commonly used in androgenetic alopecia (pattern hair loss). Each ingredient targets a different pathway involved in hair follicle function.
Minoxidil is a potassium channel opener that promotes vasodilation and increases blood flow to hair follicles, prolonging the anagen (growth) phase of the hair cycle. Finasteride is a 5-alpha reductase inhibitor that reduces the conversion of testosterone to dihydrotestosterone (DHT), the primary hormone implicated in follicular miniaturization. Melatonin has antioxidant properties and has been shown to support hair growth cycles and reduce oxidative stress in the scalp. Tretinoin (a retinoid) enhances skin cell turnover and may improve penetration of other active ingredients. Caffeine is believed to stimulate hair follicles and counteract DHT effects at the local level.
This combination is typically compounded into a topical solution for direct scalp application, aiming to address both hormonal and microcirculatory factors contributing to hair loss. While minoxidil and finasteride are well-studied individually, combination formulations are considered off-label and vary in clinical evidence.
Minoxidil is FDA-approved for androgenetic alopecia:
https://www.ncbi.nlm.nih.gov/books/NBK482378/
Finasteride’s role in reducing DHT and treating hair loss is well established:
https://www.ncbi.nlm.nih.gov/books/NBK513329/
Melatonin has demonstrated potential benefits in hair growth and scalp health:
https://pubmed.ncbi.nlm.nih.gov/12013211/